Overview

Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
0
Participant gender:
All
Summary
This is a 3-month non-interventional, observational study on patients with moderate and severe asthma.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide, Formoterol Fumarate Drug Combination
Criteria
Inclusion Criteria:

- Patients with moderate and severe asthma on Symbicort SMART treatment

Exclusion Criteria:

- Under 18 years old